Literature DB >> 32451676

Advances in stent therapy for malignant biliary obstruction.

Xin He1, Ying Zhu1, Yining Wang1,2,3, Yuanzhen Hao1,3, Junbo Hong4.   

Abstract

Malignant biliary obstruction (MBO), result of pancreatobiliary diseases is a challenging condition. Most patients with MBO are inoperable at the time of diagnosis, and the disease is poorly controlled using external-beam radiotherapy and chemotherapy. Biliary stent therapy emerged as a promising strategy for alleviating MBO and prolonging life. However, physicians find it difficult to determine the optimal type of biliary stent for the palliation of MBO. Here, we review the safety and efficacy of available biliary stents, used alone or in combination with brachytherapy, photodynamic therapy and advanced chemotherapeutics, in patients with pancreatobiliary malignancies and put forward countermeasures involving stent obstruction. Furthermore, 3D-printing stents and nanoparticle-loaded stents have broad application prospects for fabricating tailor-made biliary stents.

Entities:  

Keywords:  3D printing; Drug-eluting stent; Inoperable biliary tract carcinoma; Malignant biliary obstruction; PDT

Mesh:

Year:  2021        PMID: 32451676     DOI: 10.1007/s00261-020-02593-5

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  94 in total

1.  Results of a Japanese multicenter, randomized trial of endoscopic stenting for non-resectable pancreatic head cancer (JM-test): Covered Wallstent versus DoubleLayer stent.

Authors:  Hiroyuki Isayama; Ichiro Yasuda; Shomei Ryozawa; Hiroyuki Maguchi; Yoshinori Igarashi; Yutaka Matsuyama; Akio Katanuma; Osamu Hasebe; Atsushi Irisawa; Takao Itoi; Hidekazu Mukai; Yoshifumi Arisaka; Kazumu Okushima; Koji Uno; Mitsuhiro Kida; Kiichi Tamada
Journal:  Dig Endosc       Date:  2011-04-04       Impact factor: 7.559

2.  Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials.

Authors:  J W Valle; J Furuse; M Jitlal; S Beare; N Mizuno; H Wasan; J Bridgewater; T Okusaka
Journal:  Ann Oncol       Date:  2013-12-18       Impact factor: 32.976

3.  Self-expandable metal stents in malignant biliary obstruction: Back to the roots with uncovered stents as the "new" standard?

Authors:  Torsten Beyna; Horst Neuhaus
Journal:  Gastrointest Endosc       Date:  2018-04       Impact factor: 9.427

Review 4.  Endoscopic biliary stenting for unresectable malignant hilar obstruction.

Authors:  Mitsuharu Fukasawa; Shinichi Takano; Hiroko Shindo; Ei Takahashi; Tadashi Sato; Nobuyuki Enomoto
Journal:  Clin J Gastroenterol       Date:  2017-10-19

5.  Partially Covered Versus Uncovered Self-Expandable Metal Stents: Coating Nor Diameter Affect Clinical Outcomes.

Authors:  S P Shamah; C G Chapman; H Haider; C Liao; I Waxman; U D Siddiqui
Journal:  Dig Dis Sci       Date:  2019-04-30       Impact factor: 3.199

6.  Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: A randomized controlled trial.

Authors:  Min Jae Yang; Jin Hong Kim; Byung Moo Yoo; Jae Chul Hwang; Jun Hwan Yoo; Ki Seong Lee; Joon Koo Kang; Soon Sun Kim; Sun Gyo Lim; Sung Jae Shin; Jae Youn Cheong; Kee Myung Lee; Kwang Jae Lee; Sung Won Cho
Journal:  Scand J Gastroenterol       Date:  2015-07-01       Impact factor: 2.423

7.  Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial.

Authors:  Timothy B Gardner; Chad C Spangler; Katerina L Byanova; Gregory H Ripple; Matthew J Rockacy; John M Levenick; Kerrington D Smith; Thomas A Colacchio; Richard J Barth; Bassem I Zaki; Michael J Tsapakos; Stuart R Gordon
Journal:  Gastrointest Endosc       Date:  2016-03-10       Impact factor: 9.427

8.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  Progression of pancreatic cystic lesions without any risk features is associated with initial cyst size and obesity.

Authors:  Hye Won Park; Jong Soo Lee; Seo Young Park; Tae Hyup Kim; Ji Young Lee; Ja Eun Koo; Suh Eun Bae; Jaewon Choe; Hye-Sook Chang; Do Hyun Park; Inyoung Bae; Sungwon Park
Journal:  J Gastroenterol Hepatol       Date:  2019-12-11       Impact factor: 4.029

10.  Partially Covered Metal Stents May Not Prolong Stent Patency Compared to Uncovered Stents in Unresectable Malignant Distal Biliary Obstruction.

Authors:  Jae Yun Kim; Gyu Bong Ko; Tae Hoon Lee; Sang-Heum Park; Yun Nah Lee; Young Sin Cho; Yunho Jung; Il-Kwun Chung; Hyun Jong Choi; Sang-Woo Cha; Jong Ho Moon; Young Deok Cho; Sun-Joo Kim
Journal:  Gut Liver       Date:  2017-05-15       Impact factor: 4.519

View more
  2 in total

1.  Endoscopic retrograde cholangiopancreatography drainage for palliation of malignant hilar biliary obstruction - stent-in-stent or side-by-side? A systematic review and meta-analysis.

Authors:  Gabriel Mayo Vieira de Souza; Igor Braga Ribeiro; Mateus Pereira Funari; Diogo Turiani Hourneaux de Moura; Maria Vitória Cury Vieira Scatimburgo; João Remí de Freitas Júnior; Sergio A Sánchez-Luna; Renato Baracat; Eduardo Turiani Hourneaux de Moura; Wanderley Marques Bernardo; Eduardo Guimarães Hourneaux de Moura
Journal:  World J Hepatol       Date:  2021-05-27

Review 2.  Futuristic Developments and Applications in Endoluminal Stenting.

Authors:  Joel Ferreira-Silva; Renato Medas; Mohit Girotra; Monique Barakat; James H Tabibian; Eduardo Rodrigues-Pinto
Journal:  Gastroenterol Res Pract       Date:  2022-01-11       Impact factor: 2.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.